ABSTRACT In order to produce proteins essential for their propagation, many pathogenic human viruses, including SARS-CoV-2, the causative agent of COVID-19 respiratory disease, commandeer host biosynthetic machineries and mechanisms. Three major structural proteins, the spike, envelope and membrane proteins, are amongst several SARS-CoV-2 components synthesised at the endoplasmic reticulum (ER) of infected human cells prior to the assembly of new viral particles. Hence, the inhibition of membrane protein synthesis at the ER is an attractive strategy for reducing the pathogenicity of SARS-CoV-2 and other obligate viral pathogens. Using an in vitro system, we demonstrate that the small molecule inhibitor ipomoeassin F (Ipom-F) potently blocks the Sec61-mediated ER membrane translocation and/or insertion of three therapeutic protein targets for SARS-CoV-2 infection; the viral spike and ORF8 proteins together with angiotensin-converting enzyme 2, the host cell plasma membrane receptor. Our findings highlight the potential for using ER protein translocation inhibitors such as Ipom-F as host-targeting, broad-spectrum antiviral agents. This article has an associated First Person interview with the first author of the paper. Summary: Ipomoeassin-F blocks the Sec61-dependent translocation of SARS-CoV-2 proteins into and across the endoplasmic reticulum, highlighting the potential of Sec61 inhibitors as antiviral agents.
【저자키워드】 Endoplasmic reticulum, Cell-free translation, ER membrane complex, Sec61 translocon, Viral protein biogenesis, 【초록키워드】 COVID-19, viruses, SARS-CoV-2, SARS-COV-2 infection, in vitro, angiotensin-converting enzyme 2, Endoplasmic reticulum, Protein, Viral, membrane protein, Antiviral agents, Respiratory disease, therapeutic, envelope, structural proteins, Pathogens, Membrane proteins, small molecule, mechanisms, receptor, respiratory, pathogenicity, inhibitor, assembly, Angiotensin-converting enzyme, Sec61, angiotensin, ORF8 protein, Viral particles, SARS-CoV-2 proteins, host cell, causative agent, paper, enzyme, ORF8 proteins, pathogenic, insertion, viral spike, plasma membrane, component, SARS-CoV-2 protein, viral pathogens, translocation, human cell, block, Host, Protein target, highlight, reducing, ER membrane, biosynthetic, highlighting, Person, synthesised, 【제목키워드】 in vitro, Spike protein, receptor, host cell, host cell membrane, biogenesis, inhibit, the SARS-CoV-2,